Preconcentration of Lead in Blood and Urine Samples Among Bladder Cancer Patients Using Mesoporous Strontium Titanate Nanoparticles

Biol Trace Elem Res. 2020 Jan;193(1):100-110. doi: 10.1007/s12011-019-01704-8. Epub 2019 Apr 10.

Abstract

In this work, mesoporous strontium titanate nanoparticles (SrTiO3 NPs) were synthesized through a single-step combustion process and were characterized by FT-IR, XRD, SEM-EDX, and TEM. The effects of main parameters that may influence the extraction process (i.e., pH, sorbent amount, time of extraction, eluting agent, and the presence concomitant ions) were investigated. The optimum extraction was achieved at pH 6, 50 mg of sorbent, 20-min shaking time, and 4.0 mL of 0.1 mol L-1 thiourea as desorption agent. Under these conditions, the maximum adsorption capacity was 155.6 mg g-1 with a preconcentration factor of 250 (for a 1000 mL sample solution). The calibration graph was linear up to 1000 μg L-1 and the limit of detection was 1.75 μg L-1. The precision (as relative standard deviation) was 2.53% (n = 10). The procedure was employed for the preconcentration of Pb2+ from blood and urine samples of bladder cancer patients before its determination by FAAS.

Keywords: Bladder cancer patients; Flame atomic absorption spectrometry; Lead; Preconcentration; Strontium titanate nanoparticles.

MeSH terms

  • Aged
  • Female
  • Humans
  • Lead / urine*
  • Male
  • Middle Aged
  • Nanoparticles / chemistry*
  • Oxides / chemistry*
  • Solid Phase Extraction*
  • Strontium / chemistry*
  • Titanium / chemistry*
  • Urinary Bladder Neoplasms / urine*

Substances

  • Oxides
  • Lead
  • Titanium
  • strontium titanium oxide
  • Strontium